{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:03:09Z","timestamp":1782817389782,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","id.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.idc.2014.08.005","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T21:01:05Z","timestamp":1412542865000},"page":"601-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of Human Immunodeficiency Virus and AIDS"],"prefix":"10.1016","volume":"28","author":[{"given":"Susan E.","family":"Beekmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2014.08.005_bib1","doi-asserted-by":"crossref","first-page":"e17502","DOI":"10.1371\/journal.pone.0017502","article-title":"Estimated HIV incidence in the United States, 2006\u20132009","volume":"6","author":"Prejean","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2014.08.005_bib2","series-title":"Global report: UNAIDS report on the global AIDS epidemic 2013","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2013"},{"key":"10.1016\/j.idc.2014.08.005_bib3","first-page":"1","article-title":"Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use","volume":"39","author":"Centers for Disease Control and Prevention","year":"1990","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A\u00a0case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group","volume":"337","author":"Cardo","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2014.08.005_bib5","first-page":"1","article-title":"Antiretroviral post-exposure prophylaxis after sexual, injection-drug use, or other non-occupational exposure to HIV in the United States","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0002-9343(97)00055-7","article-title":"The role of skin dendritic cells in the initiation of human immunodeficiency virus infection","volume":"102","author":"Blauvelt","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2014.08.005_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1084\/jem.183.1.215","article-title":"Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques","volume":"183","author":"Spira","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.idc.2014.08.005_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/dna.1994.13.59","article-title":"Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity","volume":"13","author":"Ruprecht","year":"1994","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.idc.2014.08.005_bib9","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1128\/JVI.71.7.4981-4984.1997","article-title":"Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission","volume":"71","author":"Putkonen","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.idc.2014.08.005_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(97)00059-4","article-title":"Animal studies of prophylaxis","volume":"102","author":"Black","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2014.08.005_bib11","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.idc.2014.08.005_bib12","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1128\/JVI.74.20.9771-9775.2000","article-title":"Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2)","volume":"74","author":"Otten","year":"2000","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.idc.2014.08.005_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2014.08.005_bib14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJM199711203372109","article-title":"Postexposure treatment of HIV\u2013taking some risks for safety's sake","volume":"337","author":"Henderson","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2014.08.005_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/infdis\/160.2.321","article-title":"Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis","volume":"160","author":"Henderson","year":"1989","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2014.08.005_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/502178","article-title":"Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States","volume":"24","author":"Do","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2014.08.005_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajic.2012.05.016","article-title":"HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury","volume":"41","author":"Borba Brum","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2014.08.005_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/665718","article-title":"Failure of HIV postexposure prophylaxis after a work-related needlestick injury","volume":"33","author":"Camacho-Ortiz","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2014.08.005_bib19","first-page":"1","article-title":"Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib20","first-page":"1","article-title":"Updated US. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis","volume":"54","author":"Panlilio","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/502065","article-title":"Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen","volume":"23","author":"Beltrami","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2014.08.005_bib22","first-page":"12","article-title":"Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis","volume":"43","author":"Hawkins","year":"2001","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.idc.2014.08.005_bib23","unstructured":"Perdue B, Wolderufael D, Mellors J, et\u00a0al. HIV-1 transmission by a needle-stick injury despite rapid initiation of four-drug postexposure prophylaxis. Presented at the 6th Conference on retroviruses and opportunistic infections. Chicago, January 31\u2013February 4, 1999."},{"key":"10.1016\/j.idc.2014.08.005_bib24","series-title":"Principles and practice of infectious diseases","first-page":"3753","article-title":"Human immunodeficiency virus in health care settings","author":"Henderson","year":"2010"},{"key":"10.1016\/j.idc.2014.08.005_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies","volume":"9","author":"Boily","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2014.08.005_bib26","first-page":"209","article-title":"Likely female-to-female sexual transmission of HIV\u2014Texas, 2012","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/672271","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis","volume":"34","author":"Kuhar","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2014.08.005_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/COH.0b013e32833a5e6c","article-title":"Postexposure prophylaxis for HIV following sexual exposure","volume":"5","author":"Barber","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.idc.2014.08.005_bib29","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta13140","article-title":"Non-occupational postexposure prophylaxis for HIV: a systematic review","volume":"13","author":"Bryant","year":"2009","journal-title":"Health Technol Assess"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2014.08.005_bib30","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/QAI.0b013e3181fbca5a","article-title":"Progress in HIV reduction and prevention among injection and noninjection drug users","volume":"55","author":"Crawford","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.idc.2014.08.005_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/apc.2007.0157","article-title":"Nonoccupational postexposure prophylaxis for exposure to HIV in New York state emergency departments","volume":"22","author":"Ende","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.idc.2014.08.005_bib32","first-page":"210403","article-title":"High-risk sexual behavior is associated with post-exposure prophylaxis non-adherence among men who have sex with men enrolled in a combination prevention intervention","volume":"2013","author":"Fletcher","year":"2013","journal-title":"J\u00a0Sex Transm Dis"},{"key":"10.1016\/j.idc.2014.08.005_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/QAI.0b013e318278ba1b","article-title":"HIV postexposure prophylaxis in an urban population of female sex workers in Nairobi, Kenya","volume":"62","author":"Izulla","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.idc.2014.08.005_bib34","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/QAD.0b013e32832c1776","article-title":"Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men","volume":"23","author":"Poynten","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2014.08.005_bib35","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/QAD.0b013e328355375c","article-title":"HIV incidence among men who have sex with men prescribed postexposure prophylaxis","volume":"26","author":"Puro","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2014.08.005_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QCO.0b013e328012c5e0","article-title":"Postexposure prophylaxis after sexual exposure to HIV","volume":"20","author":"Roland","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idc.2014.08.005_bib37","first-page":"92","article-title":"Human bites: bloodborne pathogen risk and postexposure follow-up algorithm","volume":"105","author":"Lohiya","year":"2013","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.idc.2014.08.005_bib38","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/01.prs.0000219991.22903.eb","article-title":"Assessing risks of human immunodeficiency virus transmission by human bite injuries","volume":"117","author":"Smoot","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.idc.2014.08.005_bib39","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jana.2013.07.001","article-title":"Nonoccupational postexposure HIV prophylaxis in sexual assault programs: a survey of SANE and FNE program coordinators","volume":"25","author":"Draughon","year":"2014","journal-title":"J\u00a0Assoc Nurses AIDS Care"},{"key":"10.1016\/j.idc.2014.08.005_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13548506.2011.579984","article-title":"Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: a review","volume":"17","author":"Draughon","year":"2012","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.idc.2014.08.005_bib41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/OLQ.0b013e3181824f3c","article-title":"HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis","volume":"35","author":"Du Mont","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.idc.2014.08.005_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/675350","article-title":"Reply to Tan, et\u00a0al","volume":"35","author":"Kuhar","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2014.08.005_bib43","first-page":"1153","article-title":"Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures\u2013worldwide, 1997-2000","volume":"49","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib44","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1001\/jama.284.21.2722","article-title":"Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2014.08.005_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00126334-200402010-00003","article-title":"Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals","volume":"35","author":"Patel","year":"2004","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.idc.2014.08.005_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/324368","article-title":"Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV","volume":"34","author":"Rey","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2014.08.005_bib47","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1001\/jama.284.21.2717","article-title":"Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers","volume":"284","author":"Sha","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2014.08.005_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciu003","article-title":"A\u00a0multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City","volume":"58","author":"Gagliardo","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2014.08.005_bib49","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1060028013519246","article-title":"Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic","volume":"48","author":"Kleyn","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.idc.2014.08.005_bib50","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.4081\/idr.2013.s1.e5","article-title":"HIV drug resistance: problems and perspectives","volume":"5","author":"Pennings","year":"2013","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.idc.2014.08.005_bib51","doi-asserted-by":"crossref","first-page":"e72784","DOI":"10.1371\/journal.pone.0072784","article-title":"The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients","volume":"8","author":"Snedecor","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.idc.2014.08.005_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/hiv.12122","article-title":"Community HIV-1 drug resistance is associated with transmitted drug resistance","volume":"15","author":"Tilghman","year":"2014","journal-title":"HIV Med"},{"key":"10.1016\/j.idc.2014.08.005_bib53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200124080-00003","article-title":"Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV","volume":"24","author":"Lee","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.idc.2014.08.005_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00076-4","article-title":"Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus","volume":"102","author":"Ciesielski","year":"1997","journal-title":"Am J Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552014000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552014000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T01:49:44Z","timestamp":1650332984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552014000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0891552014000580"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2014.08.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Human Immunodeficiency Virus and AIDS","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}